LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
Clinical trial NCT07370597 · RECRUITING
Trial details
- NCT number
- NCT07370597
- Sponsor
- Jules Bordet Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-12-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.